Loading...
Thumbnail Image
Publication

Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.

Leschner, Sara
Deyneko, Igor V
Lienenklaus, Stefan
Wolf, Kathrin
Bloecker, Helmut
Bumann, Dirk
Loessner, Holger
Weiss, Siegfried
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2012-04
Submitted date
Other Titles
Abstract
Conventional cancer therapies are often limited in effectiveness and exhibit strong side effects. Therefore, alternative therapeutic strategies are demanded. The employment of tumor-colonizing bacteria that exert anticancer effects is such a novel approach that attracts increasing attention. For instance, Salmonella enterica serovar Typhimurium has been used in many animal tumor models as well as in first clinical studies. These bacteria exhibit inherent tumoricidal effects. In addition, they can be used to deliver therapeutic agents. However, bacterial expression has to be restricted to the tumor to prevent toxic substances from harming healthy tissue. Therefore, we screened an S. Typhimurium promoter-trap library to identify promoters that exclusively drive gene expression in the cancerous tissue. Twelve elements could be detected that show reporter gene expression in tumors but not in spleen and liver. In addition, a DNA motif was identified that appears to be necessary for tumor specificity. Now, such tumor-specific promoters can be used to safely express therapeutic proteins by tumor-colonizing S. Typhimurium directly in the neoplasia.
Citation
Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic. 2012, 40 (7):2984-94 Nucleic Acids Res.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1362-4962
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Archived with thanks to Nucleic acids research